Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin ?8%, ?64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan-O randomized trial

Journal article

Open access

Melanie J. Davies, Julio Rosenstock, Amar Ali, David Russell-Jones, Elisabeth Souhami, Karen Palmer, Chen Ji, Elisabeth Niemoeller and Neil Skolnik

Diabetes, obesity & metabolism, Vol.24(1), pp.34-41

01/2022

PMID: 34617398

Abstract

Original

url

https://doi.org/10.1111/dom.14543View

Published (Version of record) Open

19 Record Views

Title: Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin ?8%, ?64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan-O randomized trial
Creators: Melanie J. Davies - University Hospitals of Leicester NHS Trust
Julio Rosenstock - Dallas Diabetes Research Center
Amar Ali - Oakenhurst Medical Practice
David Russell-Jones - University of Surrey
Elisabeth Souhami - Sanofi
Karen Palmer - Sanofi
Chen Ji - Sanofi
Elisabeth Niemoeller - Sanofi
Neil Skolnik - Abington Family Medicine
Publication Details: Diabetes, obesity & metabolism, Vol.24(1), pp.34-41
Publisher: Blackwell Publishing Ltd
Date published: 01/2022
Grant note: ;
Identifiers: 99828349802346
Academic Unit: School of Biosciences
Language: English
Resource Type: Journal article
SDG (Scopus 2023): SDG 3